"Paroxetine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A serotonin uptake inhibitor that is effective in the treatment of depression.
| Descriptor ID |
D017374
|
| MeSH Number(s) |
D03.383.621.600
|
| Concept/Terms |
Paroxetine Hydrochloride- Paroxetine Hydrochloride
- Paroxetine Hydrochloride Hemihydrate
- Hemihydrate, Paroxetine Hydrochloride
- Hydrochloride Hemihydrate, Paroxetine
- Paroxetine Hydrochloride, Hemihydrate
- Hemihydrate Paroxetine Hydrochloride
- Hydrochloride, Hemihydrate Paroxetine
|
Below are MeSH descriptors whose meaning is more general than "Paroxetine".
Below are MeSH descriptors whose meaning is more specific than "Paroxetine".
This graph shows the total number of publications written about "Paroxetine" by people in this website by year, and whether "Paroxetine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 1 | 0 | 1 |
| 2002 | 1 | 0 | 1 |
| 2005 | 0 | 1 | 1 |
| 2017 | 4 | 1 | 5 |
| 2018 | 1 | 2 | 3 |
| 2019 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Paroxetine" by people in Profiles.
-
COVID-19 Pandemic-Induced Panic Disorder. Prim Care Companion CNS Disord. 2020 04 30; 22(3).
-
Ongoing initiatives within the Scottish National Health Service to affect the prescribing of selective serotonin reuptake inhibitors and their influence. J Comp Eff Res. 2019 05; 8(7):535-547.
-
Psychopharmacology and ethnicity: A comparative study on Senegalese and Italian men. World J Biol Psychiatry. 2020 04; 21(4):300-307.
-
Validation of the University of California San Diego Performance-based Skills Assessment (UPSA) in major depressive disorder: Replication and extension of initial findings. J Affect Disord. 2019 02 15; 245:508-516.
-
The complex interplay between gastrointestinal and psychiatric symptoms in irritable bowel syndrome: A longitudinal assessment. J Gastroenterol Hepatol. 2019 Apr; 34(4):713-719.
-
Pharmacological interventions for benzodiazepine discontinuation in chronic benzodiazepine users. Cochrane Database Syst Rev. 2018 Mar 15; 3:CD011481.
-
Paroxetine and fluconazole therapy for HIV-associated neurocognitive impairment: results from a double-blind, placebo-controlled trial. J Neurovirol. 2018 02; 24(1):16-27.
-
A 6-Year Posttreatment Follow-up of Panic Disorder Patients: Treatment With Clonazepam Predicts Lower Recurrence Than Treatment With Paroxetine. J Clin Psychopharmacol. 2017 Aug; 37(4):429-434.
-
Effects of escitalopram and paroxetine on mTORC1 signaling in the rat hippocampus under chronic restraint stress. BMC Neurosci. 2017 04 26; 18(1):39.
-
Randomized controlled trial of repetitive transcranial magnetic stimulation combined with paroxetine for the treatment of patients with first-episode major depressive disorder. Psychiatry Res. 2017 08; 254:18-23.